PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.24%
Revenue growth under 50% of AR's 18.84%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-7.67%
Negative gross profit growth while AR is at 2317.64%. Joel Greenblatt would examine cost competitiveness or demand decline.
-12.05%
Negative EBIT growth while AR is at 162.67%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-12.05%
Negative operating income growth while AR is at 162.67%. Joel Greenblatt would press for urgent turnaround measures.
20.83%
Net income growth under 50% of AR's 121.43%. Michael Burry would suspect the firm is falling well behind a key competitor.
9.63%
EPS growth under 50% of AR's 121.18%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
9.70%
Diluted EPS growth under 50% of AR's 120.86%. Michael Burry would worry about an eroding competitive position or excessive dilution.
9.74%
Share change of 9.74% while AR is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
10.17%
Diluted share count expanding well above AR's 3.80%. Michael Burry would fear significant dilution to existing owners' stakes.
-8.95%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
9.03%
OCF growth under 50% of AR's 18.11%. Michael Burry might suspect questionable revenue recognition or rising costs.
-62.30%
Negative FCF growth while AR is at 32.28%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
2.67%
10Y revenue/share CAGR under 50% of AR's 313.51%. Michael Burry would suspect a lasting competitive disadvantage.
46.50%
5Y revenue/share CAGR above 1.5x AR's 20.53%. David Dodd would look for consistent product or market expansions fueling outperformance.
111.30%
3Y revenue/share CAGR above 1.5x AR's 19.05%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-47.72%
Negative 10Y OCF/share CAGR while AR stands at 13.89%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-28.55%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
74.44%
Positive 3Y OCF/share CAGR while AR is negative. John Neff might see a big short-term edge in operational efficiency.
16.51%
Positive 10Y CAGR while AR is negative. John Neff might see a substantial advantage in bottom-line trajectory.
626.55%
5Y net income/share CAGR above 1.5x AR's 112.11%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
125.34%
3Y net income/share CAGR 1.25-1.5x AR's 102.97%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-4.80%
Negative equity/share CAGR over 10 years while AR stands at 216.68%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
2.66%
Positive 5Y equity/share CAGR while AR is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
108.34%
3Y equity/share CAGR above 1.5x AR's 8.31%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-58.43%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
310.98%
Dividend/share CAGR of 310.98% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
226.06%
3Y dividend/share CAGR of 226.06% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
21.27%
AR growth well above AR's 13.87%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
1.95%
Positive asset growth while AR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-6.57%
We have a declining book value while AR shows 0.42%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.14%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-19.31%
We cut SG&A while AR invests at 6.57%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.